Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: A preliminary study

Coronary Artery Disease

Volumn 11, Issue 2, 2000, Pages 171-177

  Rogacka, Dorota ^a   Guzik, Przemysław ^a   Wykrȩtowicz, Andrzej ^a   Rzeźniczak, Janusz ^b   Dziarmaga, Mieczysław ^a   Wysocki, Henryk ^a,c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b J Stru Hospital   (Poland)

^c Regional Cardio Pulmonary Hospital   (Poland)

Author keywords

Exercise treadmill test; Syndrome X; Trimetazidine

Indexed keywords

TRIMETAZIDINE;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; SYMPTOM; SYNDROME X; TREADMILL;

ADULT; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; PROBABILITY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 0034027976     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200003000-00012     Document Type: Article

References (48)

1. Kemp H. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32:375-376.
2. Cannon RO. Microvascular angina. In: Kaski JC (editor): Angina pectoris with normal coronary arteries: syndrome X. Boston: Kluwer Academic Publishers; 1994. pp. 137-148.
3. Cannon NRO, Camici PG, Epstein S. Pathophysiological dilemma of syndrome X. Circulation 1992; 85:883-892.
4. Cannon RO, Epstein SE. 'Microvascular angina' as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61:1338-1343.
5. Meeder JG, Blanksma PK, Crijns HJ, et al. Mechanism of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J 1995; 16:1571-1577.
6. Legrand V, Hodgson JM, Bates ER, et al. Abnormal coronary flow reserve and abnormal radionuclide exercise test results in patients with normal coronary angiograms. J Am Coll Cardiol 1985; 6:1245-1253.
7. Camici PG, Gistri R, et al. Coronary reserve and exercise ECG in patients with chest pain and normal coronary arteriograms. Circulation 1992; 86:179-186.
8. Geltman E, Henes C, Sennel M, Sobel B, Bergman S. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. Am J Coll Cardiol 1990; 16:586-595.
9. Boudoulas H, Cobb TC, Leighton RF, Wilt SM. Myocardial lactate production in patients with angina-like chest pain and angiographically normal coronary arteries and left ventricle. Am J Cardiol 1974; 34:501-505.
10. Opherk D, Zebe H, Weibe E, et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary angiograms. Circulation 1981; 63:817-825.
11. Maseri A. Abnormalities of oxidative metabolism. In: International workshop on chest pain with normal coronary arteriograms. London: St George's Hospital Medical School; 1997. Pp. 42-43.
12. Rosano GM, Kaski JC, Arie S, Pereira WI, Horta P, Collins P, et al. Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J 1996; 17:1175-1180.
13. Panza J, Laurienzo M, Curiel R, Unger E, Ouyyumi A, Dilsizian V, et al. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol 1997; 29:293-301.
14. Kaski JC, Crea P, Nihoyannopoulos P, Collins P, Maseri A, Poole-Wilson P. Syndrome X: clinical characteristics and left ventricular function - a long term follow-up study. Am J Coll Cardiol 1995; 25:807-814.
15. Cannon RO, Cattau EL, Yakshe PN, et al. Coronary flow reserve, esophageal motility and chest pain in patients with angiographically normal coronary arteries. Am J Med 1990; 88:217-222.
16. Montorsi P, et al. Coronary adrenergic hyperactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol 1991; 68:1698-1727.
17. Egashira K, Inou T, Hirooka Y, Yamada A, Taheshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328:1659-1664.
18. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium dependent vasodilation of the coronary resistance vessels is associated with exercise-induced myocardial ischaemia. Circulation 1995; 91:2345-2352.
19. Botker HE, Sonne HS, Sorensen KE. Frequency of systemic microvascular dysfunction in syndrome X and in variant angina. Am J Cardiol 1996; 78:182-186.
20. Cannon RO. The sensitive heart. A syndrome of abnormal cardiac pain perception. JAMA 1995; 273:11883-11887.
21. Turiel M, Galassi AR, Glazier JJ, Kaski JC, Meseri A. Pain threshold and tolerance in women with syndrome X and women with stable angina pectoris. Am J Cardiol 1987; 6:503-507.
22. Shapiro LM, Crake T, Poole-Wilson PA. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterization. BMJ 1988; 296:170-171.
23. Frober O, Arendt-Nielsen L, Bak P, Funch-Jensen P, Bagger JP. Pain perception and brain evoked potentials in patients with angina despite normal coronary angiograms. Heart 1996; 75:436-441.
24. Lagerqvist B, Sylven C, Waldenstrom A. Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms. Br Heart J 1992; 68:282-285.
25. Koglin J, Von Scheidt W. Isolated defect of adenosine-mediated coronary vasodilation: functional evidence for a new microangiopathic entity. J Am Coll Cardiol 1997; 30:103-107.
26. Waldenstrom A. Cell membrane dysfunction. In: International workshop on chest pain with normal coronary arteriograms. London: St George's Hospital Medical School; 1997. pp. 50-52.
27. Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation 1994; 90:2695-2700.
28. Montorsi P, Cozzi S, Loaldi A, Fabbiocchi F, Polese A, De Cesare N, et al. Acute coronary vasomotor effects of nifedipine and therapeutic correlates in syndrome X. Am J Cardiol 1990; 66:302-307.
29. Sutsch G, Oechslin E, Mayer I, Hess OM. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int J Cardiol 1995; 52:135-143.
30. Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol 1989; 63:286-290.
31. Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: double-blind crossover study. Cardiovasc Drugs Ther 1990; 4 (suppl 4):824-825.
32. Monpere C, Brochier M, Demange J, Ducloux G, Warin JK. Combination of trimetazidine with nifedipine in effort angina. Cardiovasc Drugs Ther 1990; 4 (suppl 4):824-825.
33. Sellier P, Audouin P, Payen B, Duong TC, Corona P, Ourbak P. Acute effects of trimetazidine evaluated by exercise testing. Eur J Clin Pharmacol 1987; 33:205-207.
34. Sellier P, et al. Chronic effects of trimetazidine on ergometric parameters in effort angina. Cardiovasc Drugs Ther 1990; 4 (suppl 4):822-823.
35. Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 1994; 37:279-288.
36. Levy S, and the Group of South of France Investigators. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Am J Cardiol 1995; 76:12B-16B.
37. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 1994; 26:949-958.
38. ++ regulation by trimetazidine during a cardiac cell acidosis. Cardiovasc Drug Ther 1988; 1:677-686.
39. Aussedat J, Ray A, Kay L, et al. Improvement of long-term preservation of isolated arrested rat heart: beneficial effect of the antiischemic agent trimetazidine. J Cardiovasc Pharmacol 1993; 21:128-135.
40. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno J. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol 1989; 63:17-20.
41. Rosano GM, Crea P. Chest pain and myocardial ischemia in syndrome X: new pathogenetic hypotheses. Coronary Artery Dis 1992; 3:599-604.
42. Rosano GM, Ponikowski P, Adampoulos S, Collins P, Poole-Wilson PA. Coats AJ, Kaski JC. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol 1994; 73:1174-1179.
43. Poole-Wilson PA. Potassium and the heart. Clin Endocrin Metab 1984; 13:249-268.
44. Tweddel AC, Martin W, et al. Thallium scans in syndrome X. Br Heart J 1992; 68:48-59.
45. Fragasso G, Rossetti E, et al. High prevalence of thallium-201 reverse redistribution phenomenon in patients with syndrome X. Eur Heart J 1996; 17:1482-1487.
46. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991; 17:499-506.
47. Crea F, Pupita G, Galassi AR, et al. Role of adenosine in pathogenesis of anginal pain. Circulation 1990; 81:164-172.
48. Meeder JG, et al. Coronary vasomotion in patients with syndrome X: evaluation with positron emission tomography and parametric myocardial perfusion imaging. Eur J Nucl Med 1997; 24:530-537.